An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
Article in Expert Opinion on Biological Therapy (June 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Expert Opinion on Biological Therapy (June 2024)
Article in Cancers (March 2024)
Article in Current Oncology (February 2024)